April 26, 2024

BREAKING NEWS

Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Support Groups | Newsletter Sign Up | Donate Now

Home » Ask The Doctor » Is Neut percentage of 30.2 normal?

Is Neut percentage of 30.2 normal?

January 17, 2022

This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.

Ask the Doctor Question:

Answer: It is important to remember to mainly pay attention to the absolute counts and ignore any percentages. You can find more information about lab values on our website located here:

https://cllsociety.org/toolbox/normal-lab-values/

There is also a good tool for tracking and trending your lab values, along with some other helpful information here:

https://cllsociety.org/toolbox/keeping-track-of-lab-results/

Ask The Doctor

Venetoclax Monotherapy for Relapsed / Refractory CLL

Phase 1 Study of BTK Degrader BGB-16673 for B-Cell Cancers

Recruiting CLL Clinical Trial: ABBV-525, a MALT1 Inhibitor

Time-Limited Ibrutinib Plus Venetoclax for CLL

Sudden Death and Arrhythmias with Acalabrutinib in CLL

Outcomes and Sequences of Targeted Therapies in CLL

CLL SOCIETY FAST FIND

One click to our most popular content.

UPCOMING
EVENTS

CLL SOCIETY
SUPPORT GROUPS

LIST OF
CLL HEALTHCARE PROVIDERS

OFFICIAL STATEMENTS AND GUIDELINES

CLL GLOSSARY

CLL SOCIETY
IN THE NEWS

ADVOCACY

QUICK LINKS

UPCOMING
EVENTS

CLL SOCIETY
SUPPORT GROUPS

LIST OF
CLL HEALTHCARE PROVIDERS

OFFICIAL STATEMENTS AND GUIDELINES

CLL GLOSSARY

CLL SOCIETY
IN THE NEWS

ADVOCACY

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Is Neut percentage of 30.2 normal?

Ask The Doctor

RECENT NEWS

Venetoclax Monotherapy for Relapsed / Refractory CLL

Phase 1 Study of BTK Degrader BGB-16673 for B-Cell Cancers

Recruiting CLL Clinical Trial: ABBV-525, a MALT1 Inhibitor

Time-Limited Ibrutinib Plus Venetoclax for CLL

Sudden Death and Arrhythmias with Acalabrutinib in CLL

Outcomes and Sequences of Targeted Therapies in CLL

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT CLL SOCIETY

CONTACT